Benzinga | Feb 9, 2021 08:01AM EST

Secondary ADS Offering Of Pre-IPO Shareholders of I-Mab Priced At $54/ADS

SHANGHAI and GAITHERSBURG, Md., Feb. 9, 2021 /PRNewswire/ -- A registered follow-on public offering by certain pre-IPO shareholders (the "Selling Shareholders") of 3,283,950 American depositary shares (the "ADSs" and such offering, the "ADS Offering") of I-Mab (the "Company") (NASDAQ:IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, has priced on February 8, 2021 at a public offering price of US$54.0 per ADS. The underwriters in the ADS Offering will have a 30-day option to purchase up to 492,590 additional ADSs from certain Selling Shareholders. Each ten (10) ADSs represent twenty-three (23) ordinary shares of the Company.